Home Zhangjiang Pharma Valley Adds Another Class III Innovative Medical Device: Intracranial Stent Approved for Market Launch

Zhangjiang Pharma Valley Adds Another Class III Innovative Medical Device: Intracranial Stent Approved for Market Launch

Jul 03, 2026 21:16 CST Updated 21:16
Skynor Medical

Vascular Minimally Invasive Intervention Product Developer

图片

Recently, the National Medical Products Administration approved the registration application for the innovative product “Intracranial Stent” submitted by Skynor Medical (Shanghai) Co., Ltd., an enterprise based in Zhangjiang Pharma Valley.


6904094b-103e-4d60-af93-4b86268cd9db.png

Image

This product consists of a stent and a delivery system, designed to be used in conjunction with embolization devices for the treatment of wide-necked saccular aneurysms in the anterior circulation of the intracranial arteries. The stent features a closed-cell helical wire interlacing design, a closed-loop structure, and full radiopacity, intended to achieve optimal flexibility and wall apposition, as well as enabling recapture and repositioning capabilities and precise stent placement.


Since the beginning of this year, Zhangjiang Pharma Valley has obtained approval for 14 Class III innovative medical devices.

Image


Source: Shanghai Medical Products Administration